zeitschrift für gastroenterologie
140285;130265;140295
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Zeitschrift für Gastroenterologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Information
Table of Contents
Imprint
Media
Authors
Instructions for Authors
Forms
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Societies
Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten mit Sektion Gastroenterologische Endoskopie
Österreichische Gesellschaft für Gastroenterologie und Hepatologie
Hungarian Society of Gastroenterology
Job Board
Job Opportunities
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
Gastroenterologie up2date
Endoscopy
Endoskopie heute
DMW - Deutsche Medizinische Wochenschrift
Related Books
Innere Medizin: Gastroenterologie
Innere Medizin: Allgemein
28. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Jaeckel, E
COMPREHENSIVE IMMUNOPHENOTYPING OF TREGS AND SERUM CYTOKINES MAY HELP TO DISTINGUISH HCV HEPATITIS FROM REJECTION IN LIVER TRANSPLANT PATIENTS
Jäger, D
The role of the tumor suppressor CYLD for the proliferation and invasion of hepatocellular carcinoma cells
Jahn-Hofmann, K
In vivo treatment with nanolipid-formulated siRNAs targeting ISG15 leads to enhanced responsiveness to interferon in primary hepatocytes
Hepatic toll-like receptors can be activated by application of siRNAs in vivo via MyD88-dependent pathways which can be controlled by chemical ribose modifications of the siRNA backbone
Jankowsky, R
Combination Treatment of Sorafenib and Resminostat, a new HDAC Inhibitor, in Patients with Sorafenib-resistant Hepatocellular Carcinoma (HCC) – Results of the Dose-Escalation Phase
Jareis, KM
Krumme Gallengänge prädisponieren zu rezidivierenden Gallengangssteinen
Jaroszewicz, J
HEV-specific T-cell responses are associated with control of HEV infection
Unexpected increase of Hepatitis B Surface Antigen (HBsAg) levels during treatment with nucleos(t)ide analogous 12–24 months before virological breakthrough and resistance
Jauch, KW
Human augmenter of liver regeneration could have a potential protective role in an alcohol-induced toxicity model
Jia, J
Telbivudine treatment improves renal function of Chronic Hepatitis B (CHB) patients
Jilg, W
Phylogenetic Characterization of HEV Isolates Derived from Acute Hepatitis E Cases in Germany 2010/2011
Xanthohumol inhibits hepatitis B virus replication in vitro
HBsAg-specific humoral and cellular immune responses in children and adolescents 8–14 years after vaccination against hepatitis B
Jochum, C
Low sodium urine concentration is associated with poor survival in patients with HRS
Jochum, J
Hepatitis C Therapie in HCV/HIV koinfizierten Patienten – eine monozentrische Kohortenstudie
Johanniemann, K
Palliative Therapie des HCC mittels transarterieller Chemoembolisation (TACE) außerhalb von Studien: Retrospektive Analyse an einem universitären Zentrum
John, C
The Role of Weight Loss (WL) as On-Tretament Predictive Factor for SVR in the Treatment of Chronic Hepatitis C (CHC) Patients with Peginterferon alfa–2A (PEG) and Ribavirin (RBV)
Confirmation of high SVR rates after shortening duration of treatment with Peginterferon alfa–2a (PEG) and Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients with RVR in Real Life
John, M
In vivo treatment with nanolipid-formulated siRNAs targeting ISG15 leads to enhanced responsiveness to interferon in primary hepatocytes
Hepatic toll-like receptors can be activated by application of siRNAs in vivo via MyD88-dependent pathways which can be controlled by chemical ribose modifications of the siRNA backbone
Joka, D
Prospektive Evaluation serologischer Biomarker des Zelltodes für den Fibrosenachweis bei chronischen Lebererkrankungen
Prospektive Evaluation serologischer Biomarker des Zelltodes zur Differenzierung von einfacher Steatose und NASH
Jonas, S
The significance of appropriate controls in surgical microRNA studies of the liver
Jones, DE
Zweitlinientherapie der Primär Biliären Zirrhose: Klinische Charakteristika und Therapieindikation–eine retrospektive Analyse
Jordan, S
Chronische Hepatitis C Infektion: Herausforderung Alter
Joschko, N
Transkriptionelle und Post-Transkriptionelle Regulation von Mcl–1 durch die p53-Familie
Identification of miRNA–34a, miRNA–145 and miRNA–149 as TAp73 and DNp73 targets in hepatocellular carcinoma
Hepatitis B Virus Infection triggers AP–1 dependent CD95Ligand expression in HepG2 cells
Jung, MC
Early versus delayed treatment of acute hepatitis C: Final results of the randomized controlled German HEP-NET acute HCV-III study
Jüngst, C
Häufigkeit und Risikofaktoren medikamentös-toxischer Leberschäden: eine umfragebasierte Studie in Apotheken
Bile acids downregulate the human hepatic organic anion transporter 7
ABCB4 deficiency is causative for hepatic copper accumulation in a patient with features of Wilson Disease